Publication Date
2009
196 p
The objective of this instrument is to help stakeholders carry out assessments to measure the level of transparency and the vulnerability to corruption in selected areas of the public pharmaceutical sector. It provides an assessment methodology together with a questionnaire for national assessors to systematically collect information and perceptions through interviews of relevant health professionals in the public and private sectors
Document No:
WHO/EMP/MAR/2009.4